A Post Marketing Evaluation of the Effectiveness of the Risk Minimization Plan For Use of FluMist Among Children Less Than 5 Years of Age.
Phase of Trial: Phase IV
Latest Information Update: 09 Oct 2014
At a glance
- Drugs Influenza virus vaccine live (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Therapeutic Use
- Sponsors MedImmune
- 09 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 May 2010 Planned end date changed from 1 Apr 2010 to 1 Jun 2011 as reported by ClinicalTrials.gov.
- 24 Mar 2009 Actual number of patients added to 316 as reported by ClinicalTrials.gov.